Rational Design and Protein Engineering of {SH2 Domain–≫ Flexible Linker–≫ Self-Controlling Peptide} Fusion System With Phosphorylation-Regulated Molecular Switch Functionality
IF 3.6 2区 生物学Q2 BIOTECHNOLOGY & APPLIED MICROBIOLOGY
Peng Zhou, Yunyi Zhang, Kexin Li, Haiyang Ye, Li Mei, Shuyong Shang
{"title":"Rational Design and Protein Engineering of {SH2 Domain–≫ Flexible Linker–≫ Self-Controlling Peptide} Fusion System With Phosphorylation-Regulated Molecular Switch Functionality","authors":"Peng Zhou, Yunyi Zhang, Kexin Li, Haiyang Ye, Li Mei, Shuyong Shang","doi":"10.1002/bit.29044","DOIUrl":null,"url":null,"abstract":"<div>\n \n <p>Self-controlling peptides (SCPs) are described as a specific sub-class of our previously proposed self-binding peptides (SBPs), which work as a molecular switch to control the protein function conversion between two or more biological states. In this study, a variety of artificial protein systems containing SCP with molecular switch functionality were rationally designed and systematically engineered by fusing several (weak and strong) phosphopeptide binders to the C-terminal tail of human Src SH2 domain via a flexible linker (FL), termed {SH2–> FL–> SCP} fusion protein systems. It is revealed that the intramolecular interaction between SH2 and SCP in the systems shares a similar binding behavior with the intermolecular interaction between SH2 and free phosphopeptide in structural and energetic points of view. In addition, FL is responsible for the binding dynamics of SCP to SH2, which restricts the SCP in a local region nearby SH2 binding site, thus equivalently enhancing the micro-concentration of SCP around the site, effectively increasing the collision frequency of SCP with the site, and consequently improving the apparent affinity of SCP to SH2. We carefully selected phosphopeptide binders and systematically optimized the sequence length and amino acid composition of FL, consequently resulting in a satisfactory {SH2–> poly(G)<sub>12</sub>–> SCP(SIPM2-K<sub>-2</sub>)} fusion protein system that was demonstrated to possess molecular switch functionality, in which the SCP binding and unbinding events were reversibly triggered by externally controlling its Tyr0-phosphorylation and pTyr0-dephosphorylation, respectively.</p></div>","PeriodicalId":9168,"journal":{"name":"Biotechnology and Bioengineering","volume":"122 9","pages":"2511-2521"},"PeriodicalIF":3.6000,"publicationDate":"2025-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biotechnology and Bioengineering","FirstCategoryId":"5","ListUrlMain":"https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/10.1002/bit.29044","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Self-controlling peptides (SCPs) are described as a specific sub-class of our previously proposed self-binding peptides (SBPs), which work as a molecular switch to control the protein function conversion between two or more biological states. In this study, a variety of artificial protein systems containing SCP with molecular switch functionality were rationally designed and systematically engineered by fusing several (weak and strong) phosphopeptide binders to the C-terminal tail of human Src SH2 domain via a flexible linker (FL), termed {SH2–> FL–> SCP} fusion protein systems. It is revealed that the intramolecular interaction between SH2 and SCP in the systems shares a similar binding behavior with the intermolecular interaction between SH2 and free phosphopeptide in structural and energetic points of view. In addition, FL is responsible for the binding dynamics of SCP to SH2, which restricts the SCP in a local region nearby SH2 binding site, thus equivalently enhancing the micro-concentration of SCP around the site, effectively increasing the collision frequency of SCP with the site, and consequently improving the apparent affinity of SCP to SH2. We carefully selected phosphopeptide binders and systematically optimized the sequence length and amino acid composition of FL, consequently resulting in a satisfactory {SH2–> poly(G)12–> SCP(SIPM2-K-2)} fusion protein system that was demonstrated to possess molecular switch functionality, in which the SCP binding and unbinding events were reversibly triggered by externally controlling its Tyr0-phosphorylation and pTyr0-dephosphorylation, respectively.
期刊介绍:
Biotechnology & Bioengineering publishes Perspectives, Articles, Reviews, Mini-Reviews, and Communications to the Editor that embrace all aspects of biotechnology. These include:
-Enzyme systems and their applications, including enzyme reactors, purification, and applied aspects of protein engineering
-Animal-cell biotechnology, including media development
-Applied aspects of cellular physiology, metabolism, and energetics
-Biocatalysis and applied enzymology, including enzyme reactors, protein engineering, and nanobiotechnology
-Biothermodynamics
-Biofuels, including biomass and renewable resource engineering
-Biomaterials, including delivery systems and materials for tissue engineering
-Bioprocess engineering, including kinetics and modeling of biological systems, transport phenomena in bioreactors, bioreactor design, monitoring, and control
-Biosensors and instrumentation
-Computational and systems biology, including bioinformatics and genomic/proteomic studies
-Environmental biotechnology, including biofilms, algal systems, and bioremediation
-Metabolic and cellular engineering
-Plant-cell biotechnology
-Spectroscopic and other analytical techniques for biotechnological applications
-Synthetic biology
-Tissue engineering, stem-cell bioengineering, regenerative medicine, gene therapy and delivery systems
The editors will consider papers for publication based on novelty, their immediate or future impact on biotechnological processes, and their contribution to the advancement of biochemical engineering science. Submission of papers dealing with routine aspects of bioprocessing, description of established equipment, and routine applications of established methodologies (e.g., control strategies, modeling, experimental methods) is discouraged. Theoretical papers will be judged based on the novelty of the approach and their potential impact, or on their novel capability to predict and elucidate experimental observations.